Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 03, 2022 at 10:01 pm
Share
Standard Chemical & Pharmaceutical Co. Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 1,549.87 million compared to TWD 1,120.84 million a year ago. Net income was TWD 238.6 million compared to TWD 159.27 million a year ago. Basic earnings per share from continuing operations was TWD 1.34 compared to TWD 0.89 a year ago. Diluted earnings per share from continuing operations was TWD 1.33 compared to TWD 0.89 a year ago. Basic earnings per share was TWD 1.34 compared to TWD 0.89 a year ago. Diluted earnings per share was TWD 1.33 compared to TWD 0.89 a year ago.
For the nine months, sales was TWD 4,268.1 million compared to TWD 3,371.01 million a year ago. Net income was TWD 640.51 million compared to TWD 533.78 million a year ago. Basic earnings per share from continuing operations was TWD 3.58 compared to TWD 2.99 a year ago. Diluted earnings per share from continuing operations was TWD 3.58 compared to TWD 2.98 a year ago. Basic earnings per share was TWD 3.58 compared to TWD 2.99 a year ago. Diluted earnings per share was TWD 3.58 compared to TWD 2.98 a year ago.
Standard Chem & Pharm Co Ltd is a Taiwan-based company principally engaged in the manufacture and sales of western pharmaceuticals, dietary supplement and active pharmaceutical ingredients. The Companyâs products cover circulatory system drugs, digestive system drugs, respiratory system drugs, nervous system drugs, metabolic drugs and general foods and health foods. The Company is also engaged in the sales of medical equipment, animal medicine, cosmetics and milk powder. The Company's products are sold to domestic and overseas markets.
STANDARD CHEMICAL & PHARMACEUTICAL CO. LTD. 
